85 related articles for article (PubMed ID: 3090175)
21. Inhibition of antigen transport by expression of infected cell peptide 47 (ICP47) prevents cell surface expression of HLA in choriocarcinoma cell lines.
Easterfield AJ; Austen BM; Westwood OM
J Reprod Immunol; 2001 Apr; 50(1):19-40. PubMed ID: 11254939
[TBL] [Abstract][Full Text] [Related]
22. Facilitating immune reaction in pregnancy and cancer.
Takeuchi S; Kanazawa K
Contrib Gynecol Obstet; 1985; 14():90-100. PubMed ID: 3864589
[No Abstract] [Full Text] [Related]
23. Immunomodulation of HLA class I and II expression on a human tumor derived cell line by 5-azacytidine, bacterial lipopolysaccharide, gamma interferon and a phorbol ester.
Santamaría M; Muñoz E; Molina I; Ortega C; Peña J
Methods Find Exp Clin Pharmacol; 1989 Apr; 11(4):269-72. PubMed ID: 2474117
[TBL] [Abstract][Full Text] [Related]
24. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
Ziai MR; Imberti L; Tongson A; Ferrone S
Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
[TBL] [Abstract][Full Text] [Related]
25. MHC antigen expression in human oral squamous carcinoma cell lines.
Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
[TBL] [Abstract][Full Text] [Related]
26. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
27. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas.
Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T
Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535
[TBL] [Abstract][Full Text] [Related]
28. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility of MHC class I expressing extravillous trophoblast cell lines to killing by natural killer cells.
Zdravkovic M; Aboagye-Mathiesen G; Guimond MJ; Hager H; Ebbesen P; Lala PK
Placenta; 1999; 20(5-6):431-40. PubMed ID: 10419808
[TBL] [Abstract][Full Text] [Related]
30. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
31. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
32. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
[TBL] [Abstract][Full Text] [Related]
33. Northern blot analysis of HLA-G expression by BeWo human choriocarcinoma cells.
Risk JM; Johnson PM
J Reprod Immunol; 1990 Sep; 18(2):199-203. PubMed ID: 2254882
[TBL] [Abstract][Full Text] [Related]
34. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
[TBL] [Abstract][Full Text] [Related]
35. Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors.
Peña J; Alonso C; Solana R; Serrano R; Carracedo J; Ramirez R
Eur J Immunol; 1990 Nov; 20(11):2445-8. PubMed ID: 1701392
[TBL] [Abstract][Full Text] [Related]
36. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
[TBL] [Abstract][Full Text] [Related]
37. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
[TBL] [Abstract][Full Text] [Related]
38. The expression of HLA on two cultured choriocarcinoma cell lines.
Tanimoto M; Takahashi T; Nishizuka Y
Gan; 1982 Feb; 73(1):27-34. PubMed ID: 6956527
[TBL] [Abstract][Full Text] [Related]
39. Cytokine (IFN-alpha, IFN-gamma, IL-1-alpha, TNF-alpha)-induced modulation of HLA cell surface expression in human breast cancer cell lines.
Sedlák J; Speiser P; Zeillinger R; Krugluger W; Wiltschke C; Kubista E; Chorváth B
Neoplasma; 1992; 39(5):269-72. PubMed ID: 1436241
[TBL] [Abstract][Full Text] [Related]
40. Surface expression of HLA-C antigen by human extravillous trophoblast.
King A; Burrows TD; Hiby SE; Bowen JM; Joseph S; Verma S; Lim PB; Gardner L; Le Bouteiller P; Ziegler A; Uchanska-Ziegler B; Loke YW
Placenta; 2000 May; 21(4):376-87. PubMed ID: 10833373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
